A Population Perspective on Ethical Compliance with Drug Trial Standards of Practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Population Perspective on Ethical Compliance with Drug Trial Standards of Practice

Published:2016-05-23 Issue:3 Volume:52 Page:829-830
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Wang Ningsheng¹,Zeng Lingfeng¹²,Zeng Xing²,Liu Jun²,Liang Weixiong³,Wang Qi¹³

Affiliation:

1. Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, China

2. Ethics Committee, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China

3. Drug Clinical Trial Institute, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference8 articles.

1. Applying for ethical approval for a national multisite study: The challenges and barriers;Kornhaber;Monash Bioeth Rev,2013

2. Ethics review as a catalyst for progress;Rosen;J Alzheimers Dis,2014

3. “It is not guaranteed that you will benefit”: True but misleading?;Kim;Clin Trials,2015

4. Do Chinese researchers conduct ethical research and use ethics committee review in clinical trials of anti-dementia drugs? An analysis of biomedical publications originating from China;Zeng;J Alzheimers Dis,2016

5. Approaches to increasing ethical compliance in China with drug trial standards of practice;Rosenberg;J Alzheimers Dis,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP